Literature DB >> 10408973

The CTLA-4 gene is associated with multiple sclerosis.

A Ligers1, C Xu, S Saarinen, J Hillert, O Olerup.   

Abstract

We have investigated whether three intragenic polymorphisms of the CTLA-4 gene, a C/T base exchange in the promoter (p.-318), an A/G substitution in exon 1 (p.49) and a dinucleotide repeat polymorphism in exon 4 (p.642), were associated with genetic susceptibility to multiple sclerosis (MS). We observed a significant association (p < 0.05) for homozygosity for the G49 allele in a case-control analysis of 378 MS patients and 237 controls, and a transmission disequilibrium (p < 0.02) for the G49 allele in 31 MS families. This was further corroborated by evidence for linkage by the affected pedigree member (APM) analysis (p < 0.0002) and a transmission distortion (p < 0.05) of the exon 4(642) polymorphism. Sequencing of the promoter, the first and second exons and the parts of the first intron revealed no further polymorphisms. Our results suggest that a dysregulation of CTLA-4-driven downregulation of T-cell activation could be involved in the pathogenesis of MS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10408973     DOI: 10.1016/s0165-5728(99)00072-7

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  20 in total

Review 1.  Immune checkpoints in central nervous system autoimmunity.

Authors:  Nicole Joller; Anneli Peters; Ana C Anderson; Vijay K Kuchroo
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

2.  Induction of the CTLA-4 gene in human lymphocytes is dependent on NFAT binding the proximal promoter.

Authors:  Heather M Gibson; Carrie J Hedgcock; Barbara M Aufiero; Adam J Wilson; Mikehl S Hafner; George C Tsokos; Henry K Wong
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

3.  Association of polymorphic alleles of CTLA4 with inflammatory bowel disease in the Japanese.

Authors:  Haruhisa Machida; Kazuhiro Tsukamoto; Chun-Yang Wen; Yukiko Narumi; Saburou Shikuwa; Hajime Isomoto; Fuminao Takeshima; Yohei Mizuta; Norio Niikawa; Ikuo Murata; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

Review 4.  Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers.

Authors:  Vera Pravica; Dusan Popadic; Emina Savic; Milos Markovic; Jelena Drulovic; Marija Mostarica-Stojkovic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

5.  Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice.

Authors:  Arthur A Hurwitz; Timothy J Sullivan; Raymond A Sobel; James P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

6.  Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease.

Authors:  T Kouki; C A Gardine; T Yanagawa; L J Degroot
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

Review 7.  CD4 T cells: Balancing the coming and going of autoimmune-mediated inflammation in the CNS.

Authors:  Bonnie N Dittel
Journal:  Brain Behav Immun       Date:  2008-01-18       Impact factor: 7.217

8.  Genetic evidence that the differential expression of the ligand-independent isoform of CTLA-4 is the molecular basis of the Idd5.1 type 1 diabetes region in nonobese diabetic mice.

Authors:  Manabu Araki; Denise Chung; Sue Liu; Daniel B Rainbow; Giselle Chamberlain; Valerie Garner; Kara M D Hunter; Lalitha Vijayakrishnan; Laurence B Peterson; Mohamed Oukka; Arlene H Sharpe; Raymond Sobel; Vijay K Kuchroo; Linda S Wicker
Journal:  J Immunol       Date:  2009-09-25       Impact factor: 5.422

Review 9.  Genetic analysis of the exon 1 position 49 CD152 dimorphism in multiple sclerosis.

Authors:  Rodney Stuart; Amy E Lovett-Racke; Elliot M Frohman; Kathleen Hawker; Michael K Racke
Journal:  J Neuroimmunol       Date:  2007-10-24       Impact factor: 3.478

10.  The CTLA-4 gene polymorphisms are associated with CTLA-4 protein expression levels in multiple sclerosis patients and with susceptibility to disease.

Authors:  Lidia Karabon; Agata Kosmaczewska; Malgorzata Bilinska; Edyta Pawlak; Lidia Ciszak; Anna Jedynak; Anna Jonkisz; Leszek Noga; Anna Pokryszko-Dragan; Magdalena Koszewicz; Irena Frydecka
Journal:  Immunology       Date:  2009-02-17       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.